In summary, BAI1 is inversely correlated with pathological grade, angiogenesis and PTBE and may be used as a marker for decreasing malignancy, neovascularization and perilesional brain edema in human astrocytomas. This evidence concerns the gene ADGRB1 and astrocytoma (excluding glioblastoma).